» Articles » PMID: 11356952

Cooperation of the V1/V2 and V3 Domains of Human Immunodeficiency Virus Type 1 Gp120 for Interaction with the CXCR4 Receptor

Overview
Journal J Virol
Date 2001 May 18
PMID 11356952
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus type 1 (HIV-1) entry is triggered by the interaction of the gp120 envelope glycoprotein with a cellular chemokine receptor, either CCR5 or CXCR4. We have identified different mutations in human CXCR4 that prevent efficient infection by one HIV-1 strain (NDK) but not another (LAI) and sought to define these strain-dependent effects at the gp120 level. The lack of activity toward the NDK strain of the HHRH chimeric CXCR4 in which the second extracellular loop (ECL2) derived from the rat CXCR4 and of CXCR4 with mutations at an aspartic acid in ECL2 (D193A and D193R) was apparently due to the sequence of the third variable loop (V3) of gp120, more precisely, to its C-terminal part. Indeed, substitution of the LAI V3 loop or only its C-terminal part in the NDK gp 120 context was sufficient to restore usage of the HHRH, D193A, and D193R receptors. The same result was achieved upon mutation of a single lysine residue of the NDK V3 loop to alanine (K319A) but not to arginine (K319R). These results provide a strong case for a direct interaction between the gp120 V3 loop and the ECL2 domain of CXCR4. By contrast, V3 substitutions had no effect on the inability of NDK to infect cells via a mutant CXCR4 in which the amino-terminal extracellular domain (NT) is deleted. In experiments with a set of chimeric NDK-LAI gp120s, the V1/V2 region from LAI gp120 was both necessary and sufficient for usage of the NT-deleted CXCR4. Different variable domains of gp120 can therefore cooperate for a functional interaction with CXCR4.

Citing Articles

Chemokine Receptor-4 Targeted PET/CT Imaging with Ga-Pentixafor in Head and Neck Cancer-A Comparison with F-FDG and CXCR4 Immunohistochemistry.

Hadebe B, Harry L, Gabela L, Masikane S, Patel M, Zwane S Diagnostics (Basel). 2024; 14(13).

PMID: 39001265 PMC: 11240717. DOI: 10.3390/diagnostics14131375.


Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors.

Lungu C, Overmars R, Grundeken E, Boers P, van der Ende M, Mesplede T Viruses. 2023; 15(11).

PMID: 38005913 PMC: 10675771. DOI: 10.3390/v15112236.


Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching.

Yu Y, Feng Y, Zhou Z, Li K, Hu X, Liao L Emerg Microbes Infect. 2023; 12(1):e2169196.

PMID: 36647730 PMC: 9980400. DOI: 10.1080/22221751.2023.2169196.


Current Status of Ga-Pentixafor in Solid Tumours.

Hadebe B, Sathekge M, Aldous C, Vorster M Diagnostics (Basel). 2022; 12(9).

PMID: 36140541 PMC: 9497673. DOI: 10.3390/diagnostics12092135.


P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent Fusion.

Soare A, Malik H, Durham N, Freeman T, Alvarez R, Patel F J Virol. 2019; 94(6).

PMID: 31852781 PMC: 7158726. DOI: 10.1128/JVI.01622-19.


References
1.
Pleskoff O, Treboute C, Brelot A, Heveker N, Seman M, Alizon M . Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry. Science. 1997; 276(5320):1874-8. DOI: 10.1126/science.276.5320.1874. View

2.
Brelot A, Heveker N, Pleskoff O, Sol N, Alizon M . Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity. J Virol. 1997; 71(6):4744-51. PMC: 191696. DOI: 10.1128/JVI.71.6.4744-4751.1997. View

3.
Ugolini S, Moulard M, Mondor I, Barois N, Demandolx D, HOXIE J . HIV-1 gp120 induces an association between CD4 and the chemokine receptor CXCR4. J Immunol. 1997; 159(6):3000-8. View

4.
Labrosse B, Pleskoff O, Sol N, Jones C, Henin Y, Alizon M . Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41. J Virol. 1997; 71(11):8230-6. PMC: 192280. DOI: 10.1128/JVI.71.11.8230-8236.1997. View

5.
Sol N, Ferchal F, Braun J, Pleskoff O, Treboute C, Ansart I . Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2. J Virol. 1997; 71(11):8237-44. PMC: 192281. DOI: 10.1128/JVI.71.11.8237-8244.1997. View